Ads
related to: zytiga
Search results
AstraZeneca's (AZN) 3 Cancer Drugs Get CHMP Nod for Expanded Use
Zacks via Yahoo Finance· 1 year agoAstraZeneca AZN and partner Merck MRK announced that the Committee for Medicinal Products for Human...
FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA
Zacks via Yahoo Finance· 1 year agoThe FDA extends the review period of AstraZeneca (AZN)/Merck's filing seeking label expansion for...
Johnson & Johnson (JNJ) Down 2.2% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 10 months agoIt has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have...
AstraZeneca's (AZN) Lynparza Gets Expanded Use Nod in Japan
Zacks via Yahoo Finance· 7 months agoAstraZeneca (AZN) gets approval for Lynparza with abiraterone and prednisolone combo in Japan to...
J&J (JNJ) Beats on Q2 Earnings & Sales, Lowers 2022 Guidance
Zacks via Yahoo Finance· 2 years agoJohnson & Johnson’s JNJ second-quarter 2022 earnings came in at $2.59 per share, which beat the...
Why Is Johnson & Johnson (JNJ) Down 0.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 month agoIt has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have...
J&J (JNJ) Beats Q3 Earnings & Sales Estimates Post Spin-Off
Zacks via Yahoo Finance· 5 months agoJohnson & Johnson’s JNJ third-quarter 2023 earnings came in at $2.66 per share, which beat the Zacks...
Why J&J Is Shifting Its Focus From Covid Shots — And Seeing A Stock Resurgence
Investor's Business Daily· 2 years agoJohnson & Johnson slashed its 2022 guidance on Tuesday and cut its Covid vaccines outlook entirely —...
J&J Sets in Motion Drug/Biotech Q1 Earnings: 3 Stocks to Buy
Zacks via Yahoo Finance· 2 years agoJohnson & Johnson JNJ is usually the first pharma company to report quarterly earnings. On Tuesday,...
Ads
related to: zytiga